The people advancing quantitative neuroscience
Our team brings together expertise across neuroscience, neuroimaging, statistics, medicine, and large-scale data science, united by a shared mission to make the brain measurable.
Jakob is a neuroscientist and entrepreneur with expertise spanning neurobiology, medical imaging, machine learning, and computational genomics. He is a Senior Scientist at the Children’s Hospital of Philadelphia and the University of Pennsylvania, where his research pioneered normative brain growth charts across the human lifespan. He earned his Ph.D. from the University of Cambridge. At Centile, Jakob leads the company’s strategy, scientific vision, and translation of cutting-edge neuroimaging research into clinical infrastructure.
Josh is a neurosurgeon-scientist with expertise in translational neuroscience, neuro-oncology, and therapeutic development. He holds appointments at MIT, Brigham and Women’s Hospital, and Boston Children’s Hospital, where his research focuses on experimental therapeutics and clinical translation. He earned his Ph.D. from the University of Cambridge and his M.D. from the University of Alabama at Birmingham. At Centile, Josh leads the company’s clinical strategy and translational partnerships.
Kelly is a product and strategy leader with over a decade of experience at the intersection of neuroscience, AI, and precision medicine. As an early employee and senior product leader at Octave Bioscience, she helped scale AI-enabled neurology diagnostics to nationwide clinical adoption while leading commercialization, product strategy, and fundraising initiatives. At Centile, Kelly leads company strategy, product development, and commercial execution as the platform expands into clinical practice.
Ariana is a healthcare technology leader with expertise in medical imaging, machine learning, and scalable cloud infrastructure. Before joining Centile, she led AI-powered imaging initiatives at the Children’s Hospital of Philadelphia, developing production-scale systems for pediatric cancer research and nationwide imaging collaborations. She earned her Ph.D. from the University of Pennsylvania. At Centile, Ariana leads software engineering, platform architecture, and the development of scalable clinical AI infrastructure.
Andrew is a machine learning engineer specializing in neuroimaging, computer vision, and clinical AI. Before joining Centile, he led R&D efforts behind two FDA-cleared neurosurgical software products as Senior Machine Learning Scientist at Turing Medical. He earned his Ph.D. in Bioengineering from Washington University in St. Louis, where his work on precision brain mapping was published in Nature, Neuron, and PNAS. At Centile, Andrew develops production-ready AI systems for quantitative neuroimaging.
Anna is a machine learning scientist specializing in AI for medical imaging, computer vision, and causal modeling. She earned her Ph.D. in Artificial Intelligence for Medical Imaging and completed research fellowships at Harvard Medical School, Mass General Brigham, KannLab, and Brigham and Women’s Hospital. At Centile, Anna develops advanced imaging AI methods spanning pediatric neuroimaging, disease modeling, and multimodal machine learning.
Nicole is a healthcare marketing leader with expertise across radiology AI, neuroimaging, and life sciences. Before joining Centile, she held marketing and communications roles at Rad AI and Cortechs.ai, helping bring AI-enabled imaging technologies to market. At Centile, Nicole leads brand strategy, marketing, product communications, and scientific storytelling as the company scales its commercial presence.
Charlie is a neuroimaging scientist with expertise in Alzheimer’s disease biomarkers, PET imaging, and quantitative neuroimaging. Before joining Centile, he was a postdoctoral research fellow at Massachusetts General Hospital and Harvard Medical School, where he led imaging studies within the Harvard Aging Brain Study and developed novel MRI and PET analysis methods for neurodegenerative disease. He earned his Ph.D. in Imaging Science from Washington University in St. Louis. At Centile, Charlie develops next-generation imaging biomarkers and multimodal AI approaches for neurodegenerative disease.
Philip is a machine learning researcher and engineer specializing in computational neuroimaging and large-scale biomedical data analysis. He earned an M.S. in Engineering Physics with a specialization in Machine Learning from Lund University. His research has spanned the University of Pennsylvania, the Children’s Hospital of Philadelphia, and Harvard Medical School, focusing on brain growth modeling, imaging biomarkers, and AI for neurological disorders. At Centile, Philip develops neuroimaging pipelines, quantitative phenotyping methods, and AI infrastructure across multimodal MRI datasets.
Aaron is a psychiatrist and neuroscientist specializing in developmental neuroimaging, network science, and imaging genetics. He is an Assistant Professor and Attending Psychiatrist at the Children’s Hospital of Philadelphia and the University of Pennsylvania. He earned his Ph.D. from the University of Cambridge and his M.D. from the University of California, Los Angeles. His work focuses on understanding how brain structure and connectivity develop across the lifespan and how these patterns relate to neuropsychiatric disease.
Hannah is a diagnostics entrepreneur, investor, and strategic advisor focused on translating biomarker technologies into commercially viable healthcare products. She is the Founder and CEO of Alva10 and Managing Partner of 10Edison, a diagnostics-focused venture fund. Her work centers on building partnerships between diagnostic companies, payers, and healthcare organizations to demonstrate clinical and economic value. She earned her M.S. from Harvard University.
Ed is a psychiatrist and neuroscientist recognized for pioneering the application of network science to the human brain. He is Regius Professor of Psychiatry at King’s College London and Emeritus Professor at the University of Cambridge. He previously served as Vice President of Experimental Medicine at GlaxoSmithKline, where he led translational neuroscience and drug-development initiatives. He earned his Ph.D. from King’s College London and his medical degree from the University of Oxford.
Richard is a neuroinformatician specializing in neurodevelopment, population neuroscience, and machine learning. He is an Assistant Professor in Neuroinformatics at the University of Cambridge, where his research uses large-scale imaging and clinical datasets to understand variation in brain development across the lifespan. He earned his Ph.D. from the University of Cambridge and has played a central role in developing population-level brain growth charts and computational models of human neurodevelopment.
Michael is a molecular imaging scientist specializing in biomarker development for Alzheimer’s disease and related neurodegenerative disorders. He is Professor of Molecular Medicine at the University of Gothenburg and a Principal Research Fellow at University College London. His work focuses on PET imaging, disease staging, and the development of translational biomarkers for clinical research and therapeutic development. He earned his Ph.D. from Karolinska Institutet.
